Frontotemporal Dementia: Bruce Willis’ Diagnosis

by | Mar 3, 2023

Dr. Stewart Stein helps us understand frontotemporal dementia, the type of dementia diagnosed in actor Bruce Willis, and provides tips to caregivers and families dealing with this disorder.

The family of Bruce Willis recently announced the actor was diagnosed with frontotemporal dementia, also known as FTD. In a statement, the family called FTD a “cruel disease” and thanked supporters for their “outpouring of love and compassion for Bruce.” How is FTD different from other forms of dementia like Alzheimer’s disease and vascular dementia? What can the family of Bruce Willis expect as the disorder progresses? Dr. Stewart Stein, Chapters Health Vice President of Medical Services, helps us understand.

What is frontotemporal dementia?

FTD refers to a group of disorders caused by progressive nerve cell loss in the brain’s frontal lobes (the areas behind your forehead) and its temporal lobes (the regions behind your ears). According to the Alzheimer’s Association, there may be between 50,000 to 60,000 people in the United States suffering from some form of FTD. It is one of the less common types of dementia, making up 10 percent to 20 percent of all dementia cases.

The Three Major Subtypes of FTD

Behavior Variant Frontotemporal Dementia (bvFTD)

People with bvFTD display changes prominently affecting their personality and behavior. It often occurs in people between the ages of 50 and 60, but can develop as early as their 20s. The nerve cell loss associated with bvFTD is prevalent in areas that control conduct, judgement, empathy and foresight. It can lead to some very troubling symptoms for family and caregivers.

“Any behavior can become disinhibited in this disease,” said Dr. Stein. “In my experience, the most distressing to families is sexual disinhibition. In this situation, a patient who has been socially competent and proper their entire life begins to make distressing sexual comments and may even inappropriately touch themselves or others.”

Primary Progressive Aphasia (PPA)

Frontotemporal dementia patient, Bruce Willis

LOS ANGELES, CA – JULY 14: Bruce Willis attends the Comedy Central Roast of Bruce Willis at Hollywood Palladium on July 14, 2018 in Los Angeles, California. (Photo by Rich Fury/Getty Images)

Doctors diagnosed Willis with aphasia last year.

PPA would mark further progression of that disorder. It is the second major form of FTD that affects language skills, speaking, writing and comprehension. It usually comes on in midlife, before the age of 65. There are major forms of PPA. The semantic variant, where individuals lose the ability to understand or formulate words in a spoken sentence. The agrammatic variant causes a person speech to be hesitant, labored or ungrammatical.

Movement Disorders

FTD can also produce movement disorders with or without behavior or language problems. The movement disorders can include progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). These disorders can cause changes in posture, and a person’s arms and legs become stiff or uncoordinated. There has also been a great deal of research linking Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig’s Disease, with the progression of frontal temporal dementia.

So, what makes FTD different from Alzheimer’s? How does the journey differ for patients and families?

Three Key Differences Between Frontotemporal Dementia and Alzheimer’s

Memory

“Alzheimer’s disease is typically noticed initially with forgetfulness, then difficulty with personal hygiene, dressing, incontinence and speech,” said Dr. Stein. “This pattern is not followed with FTD. In fact, memory tends to be somewhat spared in FTD, compared to Alzheimer’s.”

Behavior

There is also a noticeable difference in how quickly a person’s behavior changes with FTD. The behavior changes do not typically occur in Alzheimer’s patients until much later in the disease.

Spatial Orientation

Getting lost in familiar places and forgetting what time of day it is, is more common in Alzheimer’s patients compared to FTD patients. This loss in special orientation causes symptoms such as wandering, confusion and sundowning. There are differing symptoms and challenges that come with each type of dementia. So, what are some things caregivers should know about FTD patients? How can we make quality of life better for them and their loves ones?

“Therapeutic options for patients with FTD are few,” said Dr. Stein. “It would be important for caregivers to learn as much as possible about the disease and what to expect over time.”

Five Tips for Caregivers

Never Argue With a Frontotemporal Dementia Patient

This is among the many tips we provide the families of all dementia patients. Arguing or trying to reason with the person will not help. They cannot control their behaviors and they don’t understand they are unusual or upsetting to others. Trying to convince them these behaviors are unacceptable will only lead to feelings of anger and distress in a patient.

Managing Communication Problems

To foster better communications with a FTD patient, speak slowly and clearly. Use simple sentences and wait for responses. Ask them if they need clarification if they don’t understand something. Gesturing, drawing and using labeled photos of people and objects is an excellent way of enabling good communication. A speech-language pathologist can help provide similar tools and strategies for a particular person.

Prepare for the Future

Some families wait too long to make sure their loved one’s medical wishes are in place. Advance directives are an excellent tool to make sure the care they receive are in line with their wishes. While your loved one is still able to communicate, they can designate a healthcare surrogate to carry out their medical wishes and organize documents, such as physician orders for life sustaining treatment (POLST).

“POLST is an actual physician order,” said Dr. Stein. “It takes a patient’s wishes and makes them official. It’s signed by the patient and a physician. It’s a legal document that really drills down in some detail into what level of care is appropriate. It is a wonderful tool for fostering conversations and getting people to think about what they want their care to look like.”

Seek Support Groups

Caring for a dementia patient is emotionally and physically exhausting for caregivers. Support groups can be a valuable resource for families to share experiences and tips with other caregivers who may be in the same situation. Chapters Health provides free bereavement and support groups to families and caregivers. Alzheimer’s Disease Research Centers also offers education and support to families. 

Chapters Health System is committed to serving the needs of its patients, families, caregivers, health providers, partners and communities.

For more information, please call our helpful Chapters Health team at 1.866.204.8611 or Contact Us.

 

 

 

 

 

Austin Mudd

Austin Mudd

Austin Mudd, Media Relations Specialist at Chapters Health System, is responsible for external communications for the nonprofit organization. Email: [email protected]

About Us

Established in 1983 as a community-centered, nonprofit entity, Chapters Health has grown exponentially through its radical approach to healthcare that leverages a one-of-a-kind system to support patients, families, and caregivers across the country, while remaining grounded in the mission of taking care of patients, or taking care of those who do®.

Learn More

Chapters Health System Announces Selection on Hospital and Health System CFOs to Know

Willamette Vital Health Finalizes Affiliation with Chapters Health System

Nathan Adelson Hospice Finalizes Affiliation with Chapters Health System

Andrew Molosky Makes Becker’s Hospital Review 2025 Great Leaders in Healthcare List

Andrew Molosky on podcast

John J. Whyte, MD, MPH

CEO and Executive President,
American Medical Association

John Whyte, MD, MPH serves as the CEO and Executive Vice President of the American Medical Association, the nation’s largest physician organization.

Prior to the AMA, Dr. Whyte served as the Chief Medical Officer at WebMD, leading initiatives that expanded strategic partnerships, created new business opportunities, and positioned WebMD at the forefront of digital health innovation. He was a pivotal force in evolving WebMD’s digital platforms from content delivery engines to powerful tools connecting consumers directly to care, establishing critical new revenue models. He is a recognized leader in healthcare delivery and regulation and is consistently named as one of the Top 20 Health Influencers.

Before joining WebMD, Dr. Whyte served as Director of Professional Affairs and Stakeholder Engagement at the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research. There, he spearheaded groundbreaking initiatives to modernize clinical trial design, expand diversity in research, and advance the regulatory use of real-world evidence — efforts that continue to impact patient-centered drug development today.

Earlier, as Chief Medical Expert and Vice President of Health and Medical Education at Discovery Channel, Dr. Whyte launched educational programming that captured both medical and mainstream audiences, successfully aligning mission-driven health education with corporate funding strategies and building new multimedia brand identities.

At the Centers for Medicare & Medicaid Services (CMS), Dr. Whyte played a pivotal role in formalizing Medicare’s national coverage decision process, directly shaping payment policies and advancing innovative models to improve healthcare outcomes. His experience at CMS demonstrates a deep understanding of health policy, reimbursement strategies, and the critical intersection of clinical innovation and payment models.

A board-certified internist, Dr. Whyte completed his MD at Hahnemann University School of Medicine, his residency at Duke University Medical Center and earned his MPH in Health Policy and Management at Harvard University. He previously served as a health services research fellow at Stanford University. An accomplished author, Dr. Whyte has written extensively for both professional and consumer audiences, including five best-selling book

Andrew Molosky on podcast

Dr. Venki Ramakrishnan

Nobel Laureate

Venki Ramakrishnan is an American and British molecular biologist who shared the 2009 Nobel Prize in Chemistry. He currently works at the world-renowned MRC Laboratory of Molecular Biology in Cambridge, England and from 2015-2020, he served as President of the Royal Society, one of the world’s oldest scientific organizations. He is best known for his work on protein synthesis, the process by which genetic information is used by the ribosome to make the thousands of proteins that make life possible. This process is fundamental to all life and its dysfunction leads to many diseases as well as to aging. He is a member of the US National Academy of Sciences and was knighted by the British government in 2012. In 2022, he received one of Britain’s highest civilian honors, the Order of Merit, which is restricted to 24 people across all fields.

In addition to his academic work, Ramakrishnan is a science partner of the venture capital fund Ahren Innovation Capital, and on the boards of the AI-based drug development company, Isomorphic Labs, and the British Library. He recently co-founded RNAvate, an RNA therapeutics company based on stable, next-generation RNA molecules. In the public arena, he played a leadership role when he was president of the Royal Society, including dealing with the consequences of Brexit and helping convene the Society’s response to provide advice during the covid pandemic and did a significant amount of public engagement including articles in the press and appearances on national media.

Ramakrishnan is the author of two popular books: Gene Machine (2018), a very frank scientific memoir about the race for the structure of the ribosome that led to the Nobel Prize; and Why We Die: The New Science of Aging and the Quest For Immortality (2024), which looks at the biology of aging and efforts to combat it.

Andrew Molosky on podcast

Marwa El-Menshawi, MD, MPH

Chief Operating Officer, PACE Chapters Health System

Marwa El-Menshawi, MD is the Chief Operating Office for Hope PACE. She is a triple board-certified physician, specializing in Family, Geriatric and Hospice Medicine. Dr. El-Menshawi's focus is on improving the lives of those affected by advanced age and serious illness through innovation in high complexity and value-based care. She has almost 20 years of clinical, academic and healthcare leadership experience.

Dr. El-Menshawi is a member of the American Academy of Family Medicine and the National PACE Association. She serves on the Mayor's Committee for Livability and Healthy Aging, focused on serving the community through advocacy and education, recommending and promoting programs and initiatives that benefit older adults.

Dr. El-Menshawi earned her Medical Doctorate as a Magna Cum Laude graduate from the University of Alabama School of Medicine and was awarded the distinguished membership into the Alpha Omega Alpha medical honors society, along with multiple academic achievement awards including the American Medical Women's Association Glasgow-Rubin Achievement Citation, the Merck Manual Award and the Peacock Teaching Fellowship. She completed her residency in Family Medicine and Certificate of Added Qualifications in Geriatric Medicine following a Geriatrics Fellowship at Advent Health in Orlando, FL. She serves as a Clinical Assistant Professor of Geriatrics at the Florida State University College of Medicine and an Assistant Professor of Family Medicine at the University of Central Florida College of Medicine.

Andrew Molosky on podcast

Andrew Molosky

President and CEO, Chapters Health System

Andrew Molosky is the President and Chief Executive Officer of Chapters Health System, the country's defining chronic illness organization, comprised of more than 30 different companies and programs, including the nation's largest nonprofit hospice network, PACE, value-based care such as CareNu, a Medicare Advantage plan, managed services organizations, technology solutions, advanced illness offerings, and more.
Established in 1983 as a community-centered, nonprofit entity, Chapters Health has grown exponentially through Molosky's innovative approach to healthcare, becoming a national leader recognized by Great Places to Work, Fortune, USA Today, and others for being a top place to work.
As a leading voice in healthcare, Molosky is routinely engaged as a consultant, speaker, and mentor. Molosky is modeling and leading across several industries concurrently.
Molosky has more than 20 years of experience spanning an array of geographies and organizations, including publicly traded, privately held, and nonprofit. He completed his undergraduate work at the University of Toledo and his Master of Business Administration from the Ken Blanchard College of Business at Grand Canyon University, additionally holding his Fellowship from the American College of Healthcare Executives.

Share This